Suchergebnisse - "Liu, Ting-Hui"

PubPharm (70)

41

Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID-19

enthalten in: Journal of medical virology | 2023

von Wu, J. | Liu, M. | Liu, T. | +7

42

Clinical efficacy of probiotics in the treatment of patients with COVID-19 : A systematic review and meta-analysis of randomized controlled trials

enthalten in: Expert review of anti-infective therapy | 2023

von Wu, J. | Huang, P. | Liu, T. | +4

43

Clinical effectiveness of oral antiviral agents in older patients with COVID-19 based on real-world data

enthalten in: Journal of medical virology | 2023

von Tsai, Y. | Wu, J. | Liu, T. | +6

CommentIn: J Med Virol. 2023 Sep;95(9):e29086. - PMID 37695099

44

Clinical efficacy of ertapenem vs. other carbapenems for the treatment of extended-spectrum-β-lactamase-producing Enterobacterales infection : A systematic review and meta-analysis

enthalten in: Journal of global antimicrobial resistance | 2023

von Huang, P. | Hsu, C. | Liu, T. | +5

45

Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID-19 and substance use disorders based on real-world data

enthalten in: Journal of medical virology | 2023

von Liu, T. | Huang, P. | Wu, J. | +5

46

The effect of zinc on the outcome of patients with COVID-19 : A systematic review and meta-analysis of randomized controlled trials

enthalten in: The Journal of infection | 2023

von Wu, J. | Liu, T. | Huang, P. | +2

CommentOn: J Infect. 2023 Jan;86(1):66-117. - PMID 36191676

47

The association between corticosteroids and aspergillosis among COVID-19 patients

enthalten in: The Journal of infection | 2023

von Chang, Y. | Liu, T. | Wu, J. | +1

CommentOn: J Infect. 2022 Jul;85(1):57-63. - PMID 35605805

48

Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors

enthalten in: The Journal of infection | 2023

von Hsu, W. | Tsai, Y. | Wu, J. | +2

CommentOn: J Infect. 2023 Mar;86(3):248-255. - PMID 36702309

49

Efficacy of nirmatrelvir and ritonavir for post-acute COVID-19 sequelae beyond 3 months of SARS-CoV-2 infection

enthalten in: Journal of medical virology | 2023

von Chuang, M. | Wu, J. | Liu, T. | +4

50

Long-term risk of herpes zoster following COVID-19 : A retrospective cohort study of 2 442 686 patients

enthalten in: Journal of medical virology | 2023

von Chen, Y. | Ho, C. | Liu, T. | +4

CommentIn: J Med Virol. 2023 Jul;95(7):e28938. - PMID 37403920